Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial

202059 citationsJournal Articlehybrid Open Access

Authors

Administration of RSLV-132 improved severe fatigue, as determined by 4 independent patient-reported measures of fatigue, in patients with primary SS.

Good health and well-being

Published in: Arthritis & Rheumatology

Volume 73, Issue 1, pp. 143-150

Field-Weighted Citation Impact: 4.11